Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

The high mortality rate of cholangiocarcinoma (CCA) is due, in part, to the lack of non‐
invasive approaches able to accurately detect this silent tumour at early stages, when …

Intrahepatic cholangiocarcinoma (ICC) constitutes the second-most common primary
hepatic malignancy. MicroRNAs (miRNAs) play important roles in the pathogenesis of ICC …

The poor prognosis of cholangiocarcinoma (CCA) is in part due to late diagnosis, which is
currently achieved by a combination of clinical, radiological and histological approaches …

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor
with increasing incidence worldwide. The outcome of patients with iCCA is dismal owing to …

Cholangiocarcinoma (CCA) are a heterogeneous group of tumors in terms of aetiology,
natural history, morphological subtypes, molecular alterations and management, but all …

Simple Summary Cholangiocarcinoma (CCA) is a heterogenous and aggressive
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …

MicroRNAs (miRNAs) play a variety of roles in diverse biological processes at the post-
transcriptional regulatory level. Although numerous miRNAs have been identified in …

The effective management of biliary tract cancers (BTCs) has been hampered by limited
options for systemic therapy. In recent years, the focus on precision medicine has made …

Currently, cystic echinococcosis (CE) follow-up is a serious concern among surgeons.
MicroRNAs (miRNAs) are small, endogenous, non-coding RNAs which are present in …